Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.38 USD | -1.24% | -7.98% | +2.58% |
May. 08 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
May. 08 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Evolution of the average Target Price on 2seventy bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering 2seventy bio, Inc.
TD Cowen | |
Leerink Partners | |
Wedbush | |
Citigroup | |
Goldman Sachs | |
Guggenheim | |
Morgan Stanley | |
SVB Securities LLC | |
Canaccord Genuity | |
SVB Leerink | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- TSVT Stock
- Consensus 2seventy bio, Inc.